Presage Biosciences logo

Presage Biosciences

presagebio.com

Presage Biosciences develops and offers the CIVO platform, a patented technology that delivers microdoses of multiple drugs directly into different regions of a tumor within a patient to observe molecular and cellular responses. This platform provides detailed insights into the tumor microenvironment, supporting oncology researchers and drug developers in evaluating drug candidates and combinations more effectively. Its mission is to improve cancer drug development and targeting, aiming to provide more effective treatments for patients with cancer.

Facts

HQ
Seattle
Sectors
Biotechnology, Oncology, Life Sciences
Type
Corporation Seattle business license
Registered name
Presage Biosciences Inc Seattle business license
Stage
Seed

Is this your organization? Claim it

Members see Presage Biosciences's funding rounds, amounts and investors.

Online